EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

41 hedge funds and large institutions have $6.36M invested in Eiger BioPharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$750K
Puts
$159K
Net Calls
Net Calls Change

Top Buyers

1
+$861K
2
+$79.8K
3
+$69.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$43K
5
Group One Trading
Group One Trading
Illinois
+$23.9K

Top Sellers

1
-$199K
2
-$194K
3
-$171K
4
VKH
Virtu KCG Holdings
New York
-$124K
5
Two Sigma Investments
Two Sigma Investments
New York
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$18K
27
$18K
28
$14K
29
$13K
30
$11K
31
$8K
32
$6K
33
$6K
34
$5K
35
$4K
36
$2K
37
$2K
38
$1K
39
$1K
40
$1
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2